Nav: Home

Malaria resurgence directly linked to funding cuts

April 24, 2012

Funding cuts for malaria control are the single most common reason for the resurgence of the deadly disease, according to a new study that has linked overall weakened malaria control programs to the majority of global resurgences since 1930.

The study, published in the April 24 issue of the open-access Malaria Journal, analyzed the causes of 75 documented episodes of malaria resurgence throughout the world over the past 80 years, both in countries that were close to eliminating the disease and those with higher transmission rates that were attempting to control it.

Among those resurgences, 91 percent - or 68 out of the 75 - were caused at least in part by weakened malaria control programs, with 39 of the 68 tied to funding constraints, according to the research led by the Clinton Health Access Initiative, in conjunction with the UCSF Global Health Group and the Johns Hopkins Malaria Research Institute.

The study also categorized malaria resurgence according to whether it was related to increased intensity of malaria transmission due to population movement or weather changes, as well as technical obstacles such as drug and insecticide resistance. Full results can be found at www.malariajournal.com.

The results are significant in light of an estimated $9.7 billion gap between funds available and funds needed for malaria programs worldwide over the next three years, according to the international partnership Roll Back Malaria, a global partnership linked to the United Nations that is coordinating a plan among 500 member nations and organizations to eliminate the disease worldwide.

Included in that gap is the decision by the Global Fund to Fight AIDS, Tuberculosis and Malaria to postpone the majority of its malaria-based funding for new grants through 2013. As recently as 2009, the Global Fund was providing roughly half of the $2 billion in development assistance for malaria.

"We cannot afford to let history repeat itself," said Sir Richard Feachem, KBE, FREng, DSc (Med), PhD, the founding executive director of the Global Fund who now directs the UCSF Global Health Group. "It is imperative that we not lose the gains that these countries have achieved in malaria control."

Past failures to maintain such gains underscore the fragility of success in the field. Both Sri Lanka and India, for example, saw significant reductions of the illness in the 1960s, but both had dramatic resurgences when funding was withdrawn, the paper found.

In India, for example, the U.S. Agency for International Development funded an eradication program that led to a massive drop in annual malaria cases, from about 100 million in the early 20th century to about 100,000 in 1965. But when that commitment ended, malaria resurged to a peak of 6 million cases by 1976.

"Malaria control programs have been shown to be extremely successful in reducing the number of cases of malaria to very low levels, but history demonstrates that gains can be lost rapidly if financial and political support is not sustained," said lead author Justin Cohen, PhD, MPH of the Clinton Health Access Initiative. "Finding ways to ensure continued funding for malaria control today will be crucial to building on the gains of the past decade."

An estimated 216 million people contracted malaria in 2010 in 106 countries and 655,000 died from it, according to the World Health Organization (WHO), although the Institute for Health Metrics and Evaluation (IHME) estimates malaria deaths at 1.2 million that year. Nine in 10 of those deaths are in Africa, and 86 percent were in children under age five. WHO estimates that in countries where it is common, malaria can measurably lower the gross domestic product and consume nearly half of all public health expenditures.

Malaria eradication - defined as ending malaria worldwide vs. eliminating it within a specific geographic area - was a major public health effort in the first half of the 20th century and was intensively pursued after World War II. Since that effort was launched, 108 countries have eliminated malaria from within their borders, with another 36 countries moving rapidly toward that goal. Despite those efforts, almost half the world's population still lives in places where the disease is common.

Since 2000, investments in malaria control and efforts to apply low-cost solutions such as bed nets and indoor insecticide spraying on a broad scale had created unprecedented momentum in controlling malaria and brought several countries to the brink of elimination. The paper reflects the impact current funding declines could have in reversing those gains.
-end-
Researchers on the paper include Justin M. Cohen, Abigail Ward, Oliver Sabot and Bruno Moonen, from the Boston-based Clinton Health Access Initiative. Co-authors include Chris Cotter and Gavin Yamey, from the UCSF Global Health Group, and David L. Smith, from Johns Hopkins and the Center for Disease Dynamics, Economics & Policy, Washington, D.C. The publication coincides with World Malaria Day 2012, on April 25.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. Visit www.ucsf.edu.

The UCSF Global Health Group is an "action tank" dedicated to translating new approaches into large-scale action to improve the lives of millions of people. Its Malaria Elimination Initiative provides intellectual and practical support to the 36 countries that are pursuing malaria elimination. Visit globalhealthsciences.ucsf.edu/global-health-group.

Follow UCSF
UCSF.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf

University of California - San Francisco

Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.